AI factory

Bristol Myers Squibb plans NVIDIA DGX SuperPOD for drug discovery

Bristol Myers Squibb is expanding its NVIDIA infrastructure with a Vera Rubin AI factory designed to support drug discovery, proprietary models, and AI-powered scientific research.